TipRanks
Integrated BioPharma Inc (INBP)
OTHER OTC:INBP
US Market
INBP
Integrated BioPharma
RESEARCH TOOLSreports
Want to see INBP full AI Analyst Report?

Integrated BioPharma (INBP) Income Statement

10 Followers

Integrated BioPharma Income Statement

Last quarter (Q4 2026), Integrated BioPharma's total revenue was $9.80M, a decrease of -30.89% from the same quarter last year. In Q4, Integrated BioPharma's net income was $-1.37M. See Integrated BioPharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
$ 43.87M$ 54.35M$ 50.32M$ 50.67M$ 56.25M
Gross Profit
$ 800.00K$ 5.56M$ 3.88M$ 4.06M$ 6.55M
Operating Expenses
$ 3.50M$ 3.54M$ 3.63M$ 3.94M$ 3.81M
Depreciation and Amortization
$ 1.39M$ 1.27M$ 1.22M$ 1.15M$ 834.00K
EBITDA
$ -1.32M$ 3.38M$ 1.47M$ 1.27M$ 3.56M
Operating Income
$ -2.71M$ 2.02M$ 251.00K$ 120.00K$ 1.97M
Other Income/Expenses
$ 142.00K$ 42.00K$ 17.00K$ -20.00K$ -148.00K
Pretax Income
$ -2.56M$ 2.06M$ 268.00K$ 100.00K$ 2.60M
Net Income
$ -2.84M$ 808.00K$ 112.00K$ -34.00K$ 3.84M
Per Share Metrics
Basic EPS
$ -0.09$ 0.03$ 0.00$ >-0.01$ 0.13
Diluted EPS
$ -0.09$ 0.03$ 0.00$ >-0.01$ 0.12
Weighted Average Shares Outstanding
 31.06M 30.30M 30.07M 29.95M 29.84M
Weighted Average Shares Outstanding (Diluted)
 31.06M 31.17M 30.87M 29.95M 32.32M
Currency in USD

Integrated BioPharma Earnings and Revenue History